Background: Aluminum phosphide is used in different area in Iran. According to that the herbal form of these pills are used increasingly, comparison and evaluation of these patients in terms of clinical and laboratory symptoms are important. We studied on clinical and Para-clinical findings in patients who had taken aluminum phosphide and its herbal form in this study.
Methods: This is a descriptive and analytic study which carried out during 2006-2012. In this study, laboratory variables, white blood cell count, hematocrit, blood glucose, sodium, potassium and bicarbonate, arterial blood gas also clinical finding after taking aluminum phosphide pills, and vital signs of poisoned patients were extracted.
Results: In this study 386 poisoned patients were evaluated. We divided poisoned patients in two groups, case and herbal. 35% had been taking original Aluminum phosphide (case group) and 65% herbal form (herbal group). In totally 18.7% of poisoned patients were male. The average age of patients in herbal group was 23.22 ±8.20 years and in case group was 24.78±7.04 years. In both groups, nausea and vomiting were the most prevalent clinical signs. Experiments in a separate group showed significant different in blood pressure upper (P<0.001), Po2 level lower (P<0.001), pH lower (P<0.001) and bicarbonate lower (P<0.001) but there was no significant difference in respiratory rate, temperature, hemoglobin level and hematocrit. Also was observed that 70.4% of patients in case group died but all patients in herbal group survived (P<0.001).
Conclusion: The results of this study indicated that arterial blood gas of patients is a useful tool for differentiating oral poisoning with original and herbal rice pill. Hence, in patients with clinical toxicity of rice tablet can be used to differentiate these two tablets.
Babak Mostafazadeh, Esmaeil Farzaneh. Risks and Risk Factors of Repeated Suicidal Attempt: Study on Unconscious Poisoned Patients. Asia Pacific Journal Of Medical Toxicology (Apjmt). 2013;2(1):28-31.
Mehrpour O, Farzaneh E, Abdollahi M. Successful Treatment of Aluminium Phosphide Poisoning with Digoxin: A Case Report and Review of Literature. International Journal of Pharmacology. 2011;7(7):7611-764.
Babak Mostafazadeh, Esmaeil Farzaneh. A Novel Protocol for Gastric Lavage in Patients with Aluminium Phosphide Poisoning: A Double-Blind Study. Acta Med Iran. 2012;50(8):530-4.
Babak Mostafazadeh, Abdolkarim Pajoumand, Esmaeil Farzaneh, Abbas Aghabiklooei, Mohammad Reza Rasouli. Blood Levels of Methemoglobin in Patients with Aluminum Phosphide Poisoning and its Correlation with Patient’s Outcome. J. Med. Toxicol. 2011;7:40–3.
Moghaddamnia AA, Abdollahi M. An epidemiological study of poisoning in northern Islamic republic of Iran. East Mediterr Health J. 2002;8(1):88-94.
Gold Frank. Gold Franks Toxicologic emergency. 8rd ed. United states of America. Mc Graw- Hill componies. 2006;12-8.
Haddad LM, Shanon MW, Winchester JF. Clinical management of poisoning and drug overdose. 4rd ed. Philadelphia. WB saunders company. 2007;1560.
Babak Mostafazadeh. Aluminium Phosphide Poisoning, Toxicity and Drug Testing, Prof. Bill Acree (Ed.), 2012. ISBN: 978-953-51-0004-1, InTech, Available from: http://www.intechopen.com/books/toxicity-and-drugtesting/aluminium-phosphide-poisoning.
Khodabandeh F, Emamhadi MA, Mostafazadeh B. Epidemiological Assessment of Acute Poisoning Death–One Year Survey. International Journal of Medical Toxicology and Forensic Medicine. 2012;2(3):103-9.
Abdollahi M, Jalali N, sabzevari O. Pesticide poisoning during an 18 month period. (1995-1997) in Tehran, iran. Forensic Sci Int. 1999;24(3-4):77-81.
Cienki JJ. Non-anticoagulant rodenticides. Ford MD, Delaney KA, Ling LJ, Erikson T. Clinical toxicology, 1st ed, Philadelphia, W.B. Saunders Co. 2001;858.
Mehrpoor A, Shadnia SH, Soltani nejad K, Yaghmayi A. Evaluation of electrolytes and blood glucose level in aluminum phosphide poisoning. SJFM. 2009;15(1):49-53.
Rahbar Taramsary M, Orangpoor R, Zarkami T, Palizkar M, Mousavian S. Survey Patients Poisoned With Aluminum Phosphide (Rice Tablet). 2006;14(56):42-7.
Louriz M, Dendane T, Abidi K, Madani N, Abouqal R, Zeggwagh AA.Prognostic factors of acute aluminum phosphide poisoning. Indian J Med Sci. 2009;63(6):227-34.
Mathai A, Bhanu MS. Acute aluminium phosphide poisoning: Can we predict mortality?Indian J Anaesth. 2010;54(4):302-7.
Misra UK, Tripathi A K, Pandey R, Bhargwa B. Acute phosphine poisoning following ingestion of aluminium phosphide. Hum Toxicol. 1988;7(4):343-5.
Hajouji Idrissi H, Oualili L, Abidi K, Abouqal R. Severity factors of aluminium phosphide poisoning (Phostoxin). Ann Fr Anesth. 2006;25(4):382-5.
Jaiswal S, Verma R, Tewari N. Aluminum phosphide poisoning: Effect of correction of severe metabolic acidosis on patient outcome. Indian J Crit Care Med. 2009;13(1):21-4.
Soltaninejad K, Beyranvand MR, Momenzadeh SA, Shadnia S. Electrocardiographic findings and cardiac manifestations in acute aluminum phosphide poisoning. J Forensic Leg Med. 2012;19(5):291-3.